Literature DB >> 23007619

Lupus nephritis: guidelines for lupus nephritis--more recommendations than data?

Brad H Rovin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007619     DOI: 10.1038/nrneph.2012.215

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics of mycophenolic acid in severe lupus nephritis.

Authors:  Paungpaga Lertdumrongluk; Poorichaya Somparn; Wonngarm Kittanamongkolchai; Opas Traitanon; Somratai Vadcharavivad; Yingyos Avihingsanon
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

2.  Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.

Authors:  Noël Zahr; Laurent Arnaud; Pierre Marquet; Julien Haroche; Nathalie Costedoat-Chalumeau; Jean-Sébastien Hulot; Christian Funck-Brentano; Jean-Charles Piette; Zahir Amoura
Journal:  Arthritis Rheum       Date:  2010-07

3.  American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.

Authors:  Bevra H Hahn; Maureen A McMahon; Alan Wilkinson; W Dean Wallace; David I Daikh; John D Fitzgerald; George A Karpouzas; Joan T Merrill; Daniel J Wallace; Jinoos Yazdany; Rosalind Ramsey-Goldman; Karandeep Singh; Mazdak Khalighi; Soo-In Choi; Maneesh Gogia; Suzanne Kafaja; Mohammad Kamgar; Christine Lau; William J Martin; Sefali Parikh; Justin Peng; Anjay Rastogi; Weiling Chen; Jennifer M Grossman
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-06       Impact factor: 4.794

4.  Glomerular disease: Lupus nephritis treatment: are we beyond cyclophosphamide?

Authors:  Brad H Rovin
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

Review 5.  Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

Authors:  Brad H Rovin; Samir V Parikh; Lee A Hebert; Tak Mao Chan; Chi Chiu Mok; Ellen M Ginzler; Lai Seong Hooi; Paul Brunetta; Romeo Maciuca; Neil Solomons
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

6.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Authors:  Gerald B Appel; Gabriel Contreras; Mary Anne Dooley; Ellen M Ginzler; David Isenberg; David Jayne; Lei-Shi Li; Eduardo Mysler; Jorge Sánchez-Guerrero; Neil Solomons; David Wofsy
Journal:  J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 10.121

7.  The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Authors:  F A Houssiau; C Vasconcelos; D D'Cruz; G D Sebastiani; E de Ramon Garrido; M G Danieli; D Abramovicz; D Blockmans; A Cauli; H Direskeneli; M Galeazzi; A Gül; Y Levy; P Petera; R Popovic; R Petrovic; R A Sinico; R Cattaneo; J Font; G Depresseux; J-P Cosyns; R Cervera
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

8.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

  8 in total
  4 in total

1.  Mycophenolate mofetil for sustained remission in nephrotic syndrome.

Authors:  Uwe Querfeld; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2018-05-11       Impact factor: 3.714

Review 2.  Recent clinical trials in lupus nephritis.

Authors:  Michael M Ward
Journal:  Rheum Dis Clin North Am       Date:  2014-06-07       Impact factor: 2.670

Review 3.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714

4.  Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials.

Authors:  Jian-Nan Zheng; Tong-Dan Bi; Lin-Bo Zhu; Lin-Lin Liu
Journal:  Exp Ther Med       Date:  2018-07-06       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.